Revolutionary genetic drug trial will herald 'new era' in the fight against cancer

 

Health Reporter

A “revolutionary” drug trial aimed at discovering personalised treatments for the UK’s biggest cancer killer will begin this summer, scientists have announced, in an advance which experts say opens up a “new era” in the fight against cancer.

In an unprecedented partnership between cancer researchers, the NHS and the pharmaceutical industry, scientists will exploit a new understanding of the genetic properties of cancer tumours to help them identify drugs to be “targeted” at patients with specific variants of lung cancer.

Click image above to enlarge graphic

Scientists at Cancer Research UK, who have spearheaded the “genetic revolution” in cancer treatment, will be granted special access to the drugs libraries of pharmaceutical giants AstraZeneca and Pfizer from July this year.

Initially, the trials will test the effectiveness of 14 different drugs against 21 different genetic abnormalities identified in the tumours of several hundred lung cancer patients, but it is hoped that drugs which work against the various genetic varieties of every type of cancer may one day be discovered in this way.

The past decade has seen a major shift in our understanding of cancer. New technologies have allowed scientists to undertake detailed genetic analysis of cancer tumours for the first time, revealing the molecular changes that take place when cells transform from a normal part of a healthy body into a cancer cell.

Scientists have been able to identify a wide range of specific abnormalities, and cancers that were previously thought of as one condition have now been revealed to have particular genetic variants in different patients – opening up the potential for much more targeted drug treatments, known as stratified medicine.

The new trials, which will seek new treatments for patients with advanced stage, incurable lung cancer, are among the first of their kind in the world.

Professor Peter Johnson, chief clinician at Cancer Research UK, said that they marked the beginning of “a very exciting time” in the fight against cancer.

“We’ve been talking for a long while now about how the genetic revolution was going to impact cancer care and we’re really starting to bring these things together now,” he said. “We’re very excited about the trial that is going to start, where a number of different cancer drugs targeting these very specific abnormalities will be tested out.”

The trial will look at potential treatments for patients with advanced lung cancer. Small groups of patients will be identified who are likely to benefit from a certain drug. Up to 12 molecules developed by AstraZeneca will be included and two from Pfizer, but it is hoped that other pharmaceutical companies will open up their drugs libraries to cancer trials in the coming years.

Dr Harpal Kumer, Cancer Research UK’s chief executive, said that the trials would “re-write the rulebook”.

“What we’re talking about here is giving a number of options to patients who otherwise would have exhausted their treatment options,” he said. “Importantly it shifts the emphasis of designing a trial around a single drug to designing a trial that selects from a range of drugs, for a specific patient.”

X-ray of a lung cancer sufferer (Kallista Images/Getty) X-ray of a lung cancer sufferer (Kallista Images/Getty)

Lung cancer is the biggest cancer killer in the UK for men and the second-biggest for women. There are 42,000 diagnoses every year, and 35,000 people die of the disease. Globally it kills 1.6 million people a year and while rates are declining in men, women have become more susceptible in recent decades because of changes in patterns of smoking.

Dr Kumar said survival rates for the disease had remained stubbornly low, making it a good candidate for these first clinical applications of scientists’ new genetic understanding of cancer.

Menelas Pangalos, executive vice president of innovative medicines and early development at AstraZeneca, said that it was “not beyond the realms of possibility”, that the advent of targeted cancer drugs could, within a decade, transform the prospects for patients with certain types of tumour, potentially lengthening survival times dramatically.

“These [drugs] are very exciting molecules produced by our scientists, and one of the challenges we have is how to get these targeted molecules to the right patients in a cost-effective and time-effective way. [Over the next decade] we could start to offer patients a sequence of therapies that could prolong their life and make this more of a chronic illness, rather than an illness that is fatal within months,” he said.

Professor Johnson said he expected that analysing the “molecular landscape” of cancer patients’ tumours from the moment they are diagnosed would become the norm, allowing doctors to prescribe treatments aimed at the specific genetic characteristics of their cancers.

Patients from 18 Cancer Research UK centres, attached to NHS hospitals, will take part in the initial trial, which has been hailed as “ground-breaking by the Health Secretary Jeremy Hunt.

“Cancer Research UK’s stratified medicine programme will see top scientists work with industry and the NHS to collaborate on innovative, life-saving research,” Mr Hunt said. “I look forward to the benefits this will bring for cancer patients and their families.”

Arts and Entertainment
Gregg Wallace in Summer's Supermarket Secrets
tv All of this year's 15 contestants have now been named
Sport
The giant banner displayed by Legia Warsaw supporters last night
football Polish side was ejected from Champions League
Arts and Entertainment
Could we see Iain back in the Bake Off tent next week?
tv Contestant teased Newsnight viewers on potential reappearance
News
i100(and it's got nothing to do with the Great British Bake Off)
PROMOTED VIDEO
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
Life and Style
ebooksFrom the lifespan of a slug to the distance to the Sun: answers to 500 questions from readers
News
news It's not just the world that's a mess at the moment...
News
Angelina Jolie with her father Jon Voight
peopleAsked whether he was upset not to be invited, he responded by saying he was busy with the Emmy Awards
News
Bill Kerr has died aged 92
peopleBill Kerr appeared in Hancock’s Half Hour and later worked alongside Spike Milligan and Peter Sellers
Life and Style
A picture taken on January 12, 2011 shows sex shops at the Paris district of Pigalle.
news
Sport
footballPremiership preview: All the talking points ahead of this weekend's matches
News
Keira Knightley poses topless for a special September The Photographer's issue of Interview Magazine, out now
people
Voices
The Ukip leader has consistently refused to be drawn on where he would mount an attempt to secure a parliamentary seat
voicesNigel Farage: Those who predicted we would lose momentum heading into the 2015 election are going to have to think again
Arts and Entertainment
Cara Delevingne made her acting debut in Anna Karenina in 2012
film Cara Delevingne 'in talks' to star in Zoolander sequel
News
i100
Sport
Mario Balotelli pictured in his Liverpool shirt for the first time
football
Life and Style
tech
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Java Developer - 1 year contract

    £350 - £400 Per Day: Clearwater People Solutions Ltd: Our client based in Cent...

    Junior Analyst - Graduate - 6 Month fixed term contract

    £17000 - £20000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...

    SAS Business Analyst - Credit Risk - Retail Banking

    £450 - £500 per day: Orgtel: SAS Business Analyst, London, Banking, Credit Ris...

    Project Manager - Pensions

    £32000 - £38000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...

    Day In a Page

    Ukraine crisis: The phoney war is over as Russian troops and armour pour across the border

    The phoney war is over

    Russian troops and armour pour into Ukraine
    Potatoes could be off the menu as crop pests threaten UK

    Potatoes could be off the menu as crop pests threaten UK

    The world’s entire food system is under attack - and Britain is most at risk, according to a new study
    Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

    Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

    Seoul's plastic surgery industry is booming thanks to the popularity of the K-Pop look
    From Mozart to Orson Welles: Creative geniuses who peaked too soon

    Creative geniuses who peaked too soon

    After the death of Sandy Wilson, 90, who wrote his only hit musical in his twenties, John Walsh wonders what it's like to peak too soon and go on to live a life more ordinary
    Caught in the crossfire of a cyber Cold War

    Caught in the crossfire of a cyber Cold War

    Fears are mounting that Vladimir Putin has instructed hackers to target banks like JP Morgan
    Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years

    Salomé: A head for seduction

    Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years. Now audiences can meet the Biblical femme fatale in two new stage and screen projects
    From Bram Stoker to Stanley Kubrick, the British Library's latest exhibition celebrates all things Gothic

    British Library celebrates all things Gothic

    Forthcoming exhibition Terror and Wonder: The Gothic Imagination will be the UK's largest ever celebration of Gothic literature
    The Hard Rock Café's owners are embroiled in a bitter legal dispute - but is the restaurant chain worth fighting for?

    Is the Hard Rock Café worth fighting for?

    The restaurant chain's owners are currently embroiled in a bitter legal dispute
    Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival

    In search of Caribbean soul food

    Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival
    11 best face powders

    11 best face powders

    Sweep away shiny skin with our pick of the best pressed and loose powder bases
    England vs Norway: Roy Hodgson's hands tied by exploding top flight

    Roy Hodgson's hands tied by exploding top flight

    Lack of Englishmen at leading Premier League clubs leaves manager hamstrung
    Angel Di Maria and Cristiano Ronaldo: A tale of two Manchester United No 7s

    Di Maria and Ronaldo: A tale of two Manchester United No 7s

    They both inherited the iconic shirt at Old Trafford, but the £59.7m new boy is joining a club in a very different state
    Israel-Gaza conflict: No victory for Israel despite weeks of death and devastation

    Robert Fisk: No victory for Israel despite weeks of devastation

    Palestinians have won: they are still in Gaza, and Hamas is still there
    Mary Beard writes character reference for Twitter troll who called her a 'slut'

    Unlikely friends: Mary Beard and the troll who called her a ‘filthy old slut’

    The Cambridge University classicist even wrote the student a character reference
    America’s new apartheid: Prosperous white districts are choosing to break away from black cities and go it alone

    America’s new apartheid

    Prosperous white districts are choosing to break away from black cities and go it alone